Mecanismos de antioxidantes no tratamento do vitiligo in vivo: uma revisão sistemática

Autores

DOI:

https://doi.org/10.33448/rsd-v11i16.38060

Palavras-chave:

Vitiligo; Antioxidantes; Mecanismos moleculares de ação farmacológica; Bioensaio; Revisão sistemática.

Resumo

O vitiligo é caracterizado pela descoloração da pele em diferentes regiões do corpo, e sua prevalência na população mundial pode chegar a 1%. Sua causa ainda não está totalmente elucidada, mas possivelmente está relacionada a eventos bioquímicos, ambientais, imunológicos e genéticos. Além disso, indivíduos com vitiligo apresentam distúrbios eletrolíticos em seus melanócitos, e este tem sido um dos alvos de estudos para tratamento desta patologia. Esta revisão sistemática teve como objetivo reunir e avaliar estudos in vivo que descreveram o mecanismo de ação de antioxidantes no vitiligo. As bases de dados PubMed, Web of Science, Embase, Science Direct, LILACS, Open Grey e Google Scholar foram utilizadas como fonte de pesquisa. A busca incluiu todos os artigos até 16 de outubro de 2021, sem restrições de data de início. A pesquisa resultou em 390 artigos, e 7 desses foram selecionados de acordo com os critérios de inclusão. Os compostos estudados nos artigos selecionados foram curcumina, Cold Atmospheric Plasma, butina, galangina, 2',3,4,4'-tetrahidrochalcona e seus derivados, 6-benzilaminopurina, piperina, crisina, kaempferol, escopoletina, vitamina D3, ácido cafeico e luteolina. Os resultados demonstraram que os principais mecanismos de ação dos antioxidantes no tratamento do vitiligo são o aumento da atividade da tirosinase pelo aumento da síntese de TYR e TRP-1, a regulação positiva do número de células epidérmicas, o balanço redox, ativação e regulação do MITF, e conteúdo de malondialdeído e colinesterase/acetilcolinesterase. Assim, essas vias podem ser consideradas alvos para avaliação de diferentes compostos antioxidantes para atuar no tratamento do vitiligo.

Biografia do Autor

Paloma de Jesus Almeida, University of Brasilia

Department of Pharmacy, Faculty of Health Sciences

Manuel Humberto Mera Lopez, University of Brasilia

Department of Pharmacy, Faculty of Health Sciences

Suzana Guimarães de Araújo, University of Brasilia

Department of Pharmacy, Faculty of Health Sciences

Karla Braz Lopes, University of Brasilia

Department of Pharmacy, Faculty of Health Sciences

Maria de Fátima Borin, University of Brasilia

Department of Pharmacy, Faculty of Health Sciences

Referências

Abuduaini, A., Lu, X., Zang, D., Wu, T., & Aisa, H. A. (2021). Effects of a Traditional Caraway Formulation on Experimental Models of Vitiligo and Mechanisms of Melanogenesis. Evidence-Based Complementary and Alternative Medicine, 2021, 1-17. doi:10.1155/2021/6675657

Arican, O., & Kurutas, E. B. (2008). Oxidative stress in the blood of patients with active localized vitiligo. Acta Dermatovenerologica Alpina, Pannonica et Adriatica, 17(1), 12–16. Retrieved from http://s3-eu-west-1.amazonaws.com/thejournalhub/10.15570/archive/acta-apa-08-1/2.pdf

Bergqvist, C., & Ezzedine, K. (2020). Vitiligo: A Review. Dermatology, 236 (6), 1–22. doi: 10.1159/000506103

Brasil (2012). Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Ciência e Tecnologia. Diretrizes metodológicas: elaboração de revisão sistemática e metanálise de ensaios clínicos randomizados. Brasília: Editora do Ministério da Saúde. 92 p. ISBN 978-85-334-1951-3

Cordero, R. J. B., & Casadevall, A. (1997). Melanin. Current Biology, 30(4), 142–143. doi: 10.1016/j.cub.2019.12.042

Daniel, B. S., & Wittal, R. (2015). Vitiligo treatment update. Australasian Journal of Dermatology, 56(2), 85–92. doi:10.1111/ajd.12256

De Luca Canto. (2020) Revisões sistemáticas da literatura: guia prático. 1.ed., Curitiba: Brazil Publishing. ISBN 978-65-5016-352-5

Ding, Q., Luo, L., Yu, L., Huang, S. lu, Wang, X. qin, & Zhang, B. (2021). The critical role of glutathione redox homeostasis towards oxidation in ermanin-induced melanogenesis. Free Radical Biology and Medicine, 176(8), 392–405. doi:10.1016/j.freeradbiomed.2021.09.017

Ezzedine, K., Eleftheriadou, V., Whitton, M., & Van Geel, N. (2015). Vitiligo. The Lancet, 386(9988), 74–84. doi:10.1016/S0140-6736(14)60763-7

Glassman, S. J. (2011). Vitiligo, reactive oxygen species and T-cells. Clinical Science, 120(3), 99–120. doi:10.1042/CS20090603

Gonzalez, G. A., & Montminy, M. R. (1989). Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell, 59(4), 675–680. doi:10.1016/0092-8674(89)90013-5

Gowda, V. K., Srinivas, S., & Srinivasan, V. M. (2020). Waardenburg Syndrome Type I. Indian Journal of Pediatrics, 87(3), 244. doi:10.1007/s12098-019-03170-5

Guerra, L., Dellambra, E., Brescia, S., & Raskovic, D. (2010). Vitiligo: Pathogenetic Hypotheses and Targets for Current Therapies. Current Drug Metabolism, 11(5), 451–467. doi:10.2174/138920010791526105

Guo, S., & Zhang, Q. (2021). Paeonol protects melanocytes against hydrogen peroxide-induced oxidative stress through activation of Nrf2 signaling pathway. Drug Development Research, 82(6), 861–869. doi:10.1002/ddr.21793

Heriniaina, R. M., Jing, D., & Kalavagunta, P. K. (2018). Effects of six compounds with different chemical structures on melanogenesis. 16(81874331), 766–773. doi:10.1016/S1875-5364(18)30116-X

Hooijmans, C. R., Rovers, M. M., De Vries, R. B. M., Leenaars, M., Ritskes-Hoitinga, M., & Langendam, M. W. (2014). SYRCLE’s risk of bias tool for animal studies. BMC Medical Research Methodology, 14(1), 1–9. doi:10.1186/1471-2288-14-43

Huo, S. X., Gao, L., Peng, X. M., Zhao, P. P., He, Y., & Yan, M. (2014). The Effects of Galangin on a Mouse Model of Vitiligo Induced by Hydroquinone. Chinese Traditional and Herbal Drugs, 45(16), 2358–2363. doi:10.1002/ptr.5161

Huo, S. X., Wang, Q., Liu, X. M., Ge, C. H., Gao, L., Peng, X. M., & Yan

, M. (2017). The Effect of Butin on the Vitiligo Mouse Model Induced by Hydroquinone. Phytotherapy Research, 31(5), 740–746. doi:10.1002/ptr.5794

Hwang, Y. S., Oh, S. W., Park, S. H., Lee, J., Yoo, J. A., Kwon, K., Park, S. J., Kim, J., Yu, E., Cho, J. Y., & Lee, J. (2019). Melanogenic effects of maclurin are mediated through the activation of cAMP/PKA/CREB and p38 MAPK/CREB signaling pathways. Oxidative Medicine and Cellular Longevity, 2019, 1–12. doi:10.1155/2019/9827519

Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes and Development, 13(1), 76–86. doi: 10.1101/gad.13.1.76

Jung, H. M., Jung, Y. S., Lee, J. H., Kim, G. M., & Bae, J. M. (2018). Antioxidant supplements in combination with phototherapy for vitiligo: A systematic review and metaanalysis of randomized controlled trials. Journal of the American Academy of Dermatology, 85(2), 506–508. doi:10.1016/j.jaad.2018.10.010.

Karagaiah, P., Valle, Y., Sigova, J., Zerbinati, N., Vojvodic, P., Parsad, D., Schwartz, R. A., Grabbe, S., Goldust, M., & Lotti, T. (2020). Emerging drugs for the treatment of vitiligo. Expert Opinion on Emerging Drugs, 25(1), 7–24. doi:10.1080/14728214.2020.1712358

Kemp, E. H., Waterman, E. A., & Weetman, A. P. (2001). Autoimmune aspects of vitiligo. Autoimmunity, 34(1), 65–77. 10.3109/08916930108994127

Kim, H. J., Kim, J. S., Woo, J. T., Lee, I. S., & Cha, B. Y. (2015). Hyperpigmentation mechanism of methyl 3,5-di-caffeoylquinate through activation of p38 and MITF induction of tyrosinase. Acta Biochimica et Biophysica Sinica, 47(7), 548–556. doi:10.1093/abbs/gmv040

Lai, Y., Feng, Q., Zhang, R., Shang, J., & Zhong, H. (2021). The Great Capacity on Promoting Melanogenesis of Three Compatible Components in Vernonia anthelmintica ( L .) Willd . 22(8), 1-18. doi: 10.3390/ijms22084073

Macleod, M. R., O’Collins, T., Howells, D. W., & Donnan, G. A. (2004). Pooling of animal experimental data reveals influence of study design and publication bias. Stroke, 35(5), 1203–1208. doi:10.1161/01.STR.0000125719.25853.20

Mansourpour, H., Ziari, K., Kalantar Motamedi, S., & Hassan Poor, A. (2019). iNOS inhibition for vitiligo Therapeutic effects of iNOS inhibition against vitiligo in an animal model. Eur J Transl Myol, 29(3), 251–260. doi:10.4081/ejtm.2019.8383

Meneghin, R. A. (2021). Quali-quantitative synthesis of the global scenario of patent families about leprosy. Ciência & Saúde Coletiva, 26(11), 5411–5426. doi:10.1590/1413-812320212611.01452021

Nichols, J. A., & Katiyar, S. K. (2010). Skin photoprotection by natural polyphenols: Anti-inflammatory, antioxidant and DNA repair mechanisms. Archives of Dermatological Research, 302(2), 71–83. doi:10.1007/s00403-009-1001-3

Niture, S. K., Khatri, R., & Jaiswal, A. K. (2014). Regulation of Nrf2 - An update. Free Radical Biology and Medicine, 66, 36–44. doi:10.1016/j.freeradbiomed.2013.02.008

Niu, C., & Aisa, H. A. (2017). Upregulation of Melanogenesis and Tyrosinase Activity: Potential Agents for Vitiligo. Molecules, 22(8). doi:10.3390/molecules22081303

Niu, C., Yin, L., & Aisa, H. A. (2018). Novel furocoumarin derivatives stimulate melanogenesis in b16 melanoma cells by up-regulation of mitf and tyr family via Akt/GSK3β/β-catenin signaling pathways. International Journal of Molecular Sciences, 19(3). doi:10.3390/ijms19030746

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas. Revista Española de Cardiología, 74(9), 790–799. doi: 10.1016/j.rec.2021.07.010

Picardo, M., Dell’Anna, M. L., Ezzedine, K., Hamzavi, I., Harris, J. E., Parsad, D., & Taieb, A. (2015). Vitiligo. Nature Reviews Disease Primers, 1. 1-16. doi:10.1038/nrdp.2015.11

Pillaiyar, T., Manickam, M., & Jung, S. H. (2017). Downregulation of melanogenesis: drug discovery and therapeutic options. Drug Discovery Today, 22(2), 282–298. doi:10.1016/j.drudis.2016.09.016

Pizzinat, N., Copin, N., Vindis, C., Parini, A., & Cambon, C. (1999). Reactive oxygen species production by monoamine oxidases in intact cells. Naunyn-Schmiedeberg’s Archives of Pharmacology, 359(5), 428–431. doi:10.1007/pl00005371

Rashighi, M., & Harris, J. E. (2017). Vitiligo Pathogenesis and Emerging Treatments. Dermatologic Clinics, 35(2), 257–265. doi:10.1016/j.det.2016.11.014

Rawls, J. F., & Johnson, S. L. (2000). Zebrafish kit mutation reveals primary and secondary regulation of melanocyte development during fin stripe regeneration. Development, 127(17), 3715–3724. doi:10.1242/dev.127.17.3715

Rezaei, N., Gavalas, N. G., Weetman, A. P., & Kemp, E. H. (2007). Autoimmunity as an aetiological factor in vitiligo. Journal of the European Academy of Dermatology and Venereology, 21(7), 865–876. doi:10.1111/j.1468-3083.2007.02228.x

Rzepka, Z., Buszman, E., Beberok, A., & Wrześniok, D. (2016). From tyrosine to melanin: Signaling pathways and factors regulating melanogenesis. Postepy Higieny i Medycyny Doswiadczalnej, 70, 695–708. doi:10.5604/17322693.1208033

Salzes C, Abadie S, Seneschal J, Whitton M, Meurant JM, Jouary T, Ballanger F, Boralevi F, Taieb A, Taieb C, Ezzedine K.(2015). The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool. 136(1), 52-8 doi:10.1038/JID.2015.398

Schallreuter, K. U., & Elwary, S. (2007). Hydrogen peroxide regulates the cholinergic signal in a concentration dependent manner. Life Sciences, 80(24–25), 2221–2226. doi:10.1016/j.lfs.2007.01.028

Schallreuter, K. U., Elwary, S. M. A., Gibbons, N. C. J., Rokos, H., & Wood, J. M. (2004). Activation/deactivation of acetylcholinesterase by H2O 2: More evidence for oxidative stress in vitiligo. Biochemical and Biophysical Research Communications, 315(2), 502–508. doi:10.1016/j.bbrc.2004.01.082

Schallreuter, K. U., Moore, J., Wood, J. M., Beazley, W. D., Gaze, D. C., Tobin, D. J., Marshall, H. S., Panske, A., Panzig, E., & Hibberts, N. A. (1999). In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. Journal of Investigative Dermatology Symposium Proceedings, 4(1), 91–96. doi:10.1038/sj.jidsp.5640189

Seneschal, J., Boniface, K., D’Arino, A., & Picardo, M. (2021). An update on Vitiligo pathogenesis. Pigment Cell and Melanoma Research, 34(2), 236–243. doi:10.1111/pcmr.12949

Serre, C., Busuttil, V., & Botto, J. M. (2018). Intrinsic and extrinsic regulation of human skin melanogenesis and pigmentation. International Journal of Cosmetic Science, 40(4), 328–347. doi:10.1111/ics.12466

Speeckaert, R., Dugardin, J., Lambert, J., Lapeere, H., Verhaeghe, E., Speeckaert, M. M., & van Geel, N. (2018). Critical appraisal of the oxidative stress pathway in vitiligo: a systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology, 32(7), 1089–1098. doi:10.1111/jdv.14792

Sun, M. C., Xu, X. L., Lou, X. F., & Du, Y. Z. (2020). Recent progress and future directions: The nano-drug delivery system for the treatment of vitiligo. International Journal of Nanomedicine, 15, 3267–3279. doi:10.2147/IJN.S245326

Tipton, K. F. (2018). 90 Years of Monoamine Oxidase: Some Progress and Some Confusion. Journal of Neural Transmission, 125(11), 1519-1551. doi:10.1007/s00702-018-1881-5

Turrens, J. F. (2003). Mitochondrial formation of reactive oxygen species. Journal of Physiology, 552(2), 335–344. doi:10.1113/jphysiol.2003.049478

Van Den Wijngaard, R., Wankowicz-Kalinska, A., Pals, S., Weening, J., & Das, P. (2001). Autoimmune melanocyte destruction in vitiligo. Laboratory Investigation, 81(8), 1061–1067. doi:10.1038/labinvest.3780318

Videira, I. F. D. S., Moura, D. F. L., & Magina, S. (2013). Mechanisms regulating melanogenesis*. Anais Brasileiros de Dermatologia, 88(1), 76–83. doi:10.1590/s0365-05962013000100009

Wang, Y., Li, S., & Li, C. (2019). Perspectives of new advances in the pathogenesis of vitiligo: From oxidative stress to autoimmunity. Medical Science Monitor, 25, 1017–1023. doi:10.12659/MSM.914898

Wu, L. C., Lin, Y. Y., Yang, S. Y., Weng, Y. T., & Tsai, Y. T. (2011). Antimelanogenic effect of c-phycocyanin through modulation of tyrosinase expression by upregulation of ERK and downregulation of p38 MAPK signaling pathways. Journal of Biomedical Science, 18(1), 1–11. doi:10.1186/1423-0127-18-74

Xia, J., Zeng, W., Xia, Y., Wang, B., Xu, D., Liu, D., Kong, M. G., & Dong, Y. (2019). Cold atmospheric plasma induces apoptosis of melanoma cells via Sestrin2-mediated nitric oxide synthase signaling. Journal of Biophotonics, 12(1), 1–20. doi:10.1002/jbio.201800046

Xie, H., Zhou, F., Liu, L., Zhu, G., Li, Q., Li, C., & Gao, T. (2016). Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity? Journal of Dermatological Science, 81(1), 3–9. doi:10.1016/j.jdermsci.2015.09.003

Yildirim, M., Baysal, V., Inaloz, H. S., & Can, M. (2004). The role of oxidants and antioxidants in generalized vitiligo at tissue level. Journal of the European Academy of Dermatology and Venereology, 18(6), 683–686. doi:10.1111/j.1468-3083.2004.01080.x

Zang, D., Niu, C., & Aisa, H. A. (2019). Amine derivatives of furocoumarin induce melanogenesis by activating Akt/GSK-3β/ β-catenin signal pathway. Drug Design, Development and Therapy, 13, 623–632. doi:10.2147/DDDT.S180960

Zhai, S., Xu, M., Li, Q., Guo, K., Chen, H., & Kong, M. G. (2021). Successful Treatment of Vitiligo with Cold Atmospheric Plasma ‒ Activated Hydrogel. Journal of Investigative Dermatology, 141(11), 2710-2719. doi:10.1016/j.jid.2021.04.019

Zhang, J., Hu, W., Wang, P., Ding, Y., Wang, H., & Kang, X. (2022). Research Progress on Targeted Antioxidant Therapy and Vitiligo. Oxidative Medicine and Cellular Longevity, 2022, 1–9. doi:10.1155/2022/1821780

Zhong, H., Zhou, J., An, X., Hua, Y., Lai, Y., Zhang, R., Ahmad, O., Zhang, Y., & Shang, J. (2019). Natural product-based design, synthesis and biological evaluation of 2′,3,4,4′-tetrahydrochalcone analogues as antivitiligo agents. 87, 523–533. doi:10.1016/j.bioorg.2019.03.054

Zouboulis, C. C., & Makrantonaki, E. (2011). Clinical aspects and molecular diagnostics of skin aging. Clinics in Dermatology, 29(1), 3–14. doi:10.1016/j.clindermatol.2010.07.001

Downloads

Publicado

08/12/2022

Como Citar

ALMEIDA, P. de J.; MERA LOPEZ, M. H. .; ARAÚJO, S. G. de; LOPES, K. B.; BORIN, M. de F. Mecanismos de antioxidantes no tratamento do vitiligo in vivo: uma revisão sistemática. Research, Society and Development, [S. l.], v. 11, n. 16, p. e277111638060, 2022. DOI: 10.33448/rsd-v11i16.38060. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/38060. Acesso em: 23 dez. 2024.

Edição

Seção

Artigos de Revisão